Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Hypoglycemia – a condition in which low blood glucose levels can cause you to feel dizzy, weak, and shaky – can catch you by ...

The new implant contains a reservoir of glucagon that sits beneath the skin and can be activated in an emergency, with no need for injections. For individuals with Type 1 diabetes, the risk of ...

For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...

A new implantable device developed by engineers at MIT can release glucagon without any external effort. The implant, which ...

MIT’s wireless skin implant delivers glucagon instantly when blood sugar drops, offering new safety for diabetics, even while ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

Hormones can be helpful heroes, supporting the immune system and a healthy sleep-wake schedule. But they can also be culprits ...

A team of US researchers has developed a novel implantable device that can save people with Type 1 diabetes from developing ...

MIT engineers have made tremendous progress in revolutionising Type 1 diabetes management with their groundbreaking emergency ...

Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan ...

Medicine, lifestyle changes, and surgery can return glucose levels to normal or nearly normal in some type 2 diabetes ...